PISANI, Francesco
 Distribuzione geografica
Continente #
EU - Europa 7.631
NA - Nord America 6.773
AS - Asia 3.853
SA - Sud America 1.797
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 101
OC - Oceania 10
Totale 20.269
Nazione #
US - Stati Uniti d'America 6.620
RU - Federazione Russa 3.714
SG - Singapore 1.706
BR - Brasile 1.571
CN - Cina 1.056
IE - Irlanda 961
SE - Svezia 760
IT - Italia 526
HK - Hong Kong 441
UA - Ucraina 409
DE - Germania 396
FR - Francia 271
VN - Vietnam 202
FI - Finlandia 197
GB - Regno Unito 161
IN - India 101
AR - Argentina 79
PL - Polonia 64
CA - Canada 58
IQ - Iraq 50
TR - Turchia 50
MX - Messico 43
BD - Bangladesh 38
EC - Ecuador 37
NL - Olanda 36
AT - Austria 35
ZA - Sudafrica 29
BE - Belgio 28
UZ - Uzbekistan 26
MA - Marocco 24
CO - Colombia 23
JP - Giappone 23
PK - Pakistan 23
VE - Venezuela 20
ID - Indonesia 18
CL - Cile 17
PY - Paraguay 17
JM - Giamaica 16
PE - Perù 14
SA - Arabia Saudita 13
ES - Italia 11
LT - Lituania 10
OM - Oman 10
TN - Tunisia 10
BO - Bolivia 9
IR - Iran 9
JO - Giordania 9
PA - Panama 9
PH - Filippine 9
UY - Uruguay 9
CZ - Repubblica Ceca 8
KE - Kenya 8
KZ - Kazakistan 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
AU - Australia 6
CH - Svizzera 6
CR - Costa Rica 6
EG - Egitto 6
HN - Honduras 6
AZ - Azerbaigian 5
KR - Corea 5
RS - Serbia 5
DZ - Algeria 4
ET - Etiopia 4
KG - Kirghizistan 4
LB - Libano 4
LV - Lettonia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
EU - Europa 3
GR - Grecia 3
MY - Malesia 3
PS - Palestinian Territory 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
KW - Kuwait 2
MK - Macedonia 2
NG - Nigeria 2
NP - Nepal 2
SI - Slovenia 2
SV - El Salvador 2
TG - Togo 2
TT - Trinidad e Tobago 2
Totale 20.151
Città #
Moscow 1.240
Dublin 958
Jacksonville 828
Singapore 806
Chandler 699
Ashburn 672
Dallas 501
Hong Kong 441
Beijing 389
Nyköping 321
Council Bluffs 265
The Dalles 236
San Jose 223
Dearborn 193
Princeton 189
Cambridge 179
Lauterbourg 167
Los Angeles 166
Des Moines 148
Medford 125
São Paulo 117
Ann Arbor 116
Boardman 98
Buffalo 91
Ho Chi Minh City 85
New York 83
Warsaw 59
Rio de Janeiro 57
Tianjin 54
Messina 51
Wilmington 48
Woodbridge 47
Munich 44
Hanoi 40
San Mateo 40
Shenyang 40
Belo Horizonte 38
Milan 37
Guangzhou 36
Houston 36
Jinan 35
Orem 34
Rome 34
Redondo Beach 30
Nanjing 29
Santa Clara 29
Brussels 27
Curitiba 27
Frankfurt am Main 25
Columbus 24
Seattle 24
Vienna 24
Tashkent 23
Bremen 22
Brooklyn 22
Pune 22
Salvador 22
Atlanta 20
Hebei 20
Porto Alegre 20
Amsterdam 19
Brasília 19
Campinas 19
Chicago 19
Montreal 18
Stockholm 18
Tokyo 18
Chennai 17
Manchester 17
Mumbai 17
Phoenix 17
Denver 16
Norwalk 16
Shanghai 16
Zhengzhou 16
Fortaleza 15
Guayaquil 15
Jiaxing 15
Ningbo 15
Shenzhen 15
Guarulhos 14
Hangzhou 14
Lancaster 14
Ribeirão Preto 14
Helsinki 13
Istanbul 13
Johannesburg 13
Poplar 13
Fuzhou 12
Haikou 12
London 12
Mexico City 12
Naples 12
Recife 12
Baghdad 11
Caruaru 11
Goiânia 11
Nuremberg 11
Sorocaba 11
Muscat 10
Totale 11.058
Nome #
" Stato confusionale di probabile natura iatrogena"; " Verosimile screzio psicotico"; " Sindrome Cefalalgica"; " Disturbo d'Ansia". Varie ipotesi ed una sola diagnosi: SENC 452
Antiepileptic drugs and MTHFR Polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients 216
"Valproic acid-amitriptyline interaction in man 204
ALLOPURINOL AS ADD-ON THERAPY IN REFRACTORY EPILEPSY - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY 199
Hyperhomocysteinemia in patients with epilepsy: does it play a role in the pathogenesis of brain atrophy? A preliminary report. 193
ATTENTION CHARACTERIZATION IN PATIENTS WITH FRONTAL AND TEMPORAL LOBE EPILEPSY 189
beneficial effect of donezepil in a malnourished surgical patient with severe nonalcoholic wernicke's encephalopathy 185
Distribuzione di due polimorfismi genici della MTHFR in pazienti con Epilessia e correlazione con i livelli serici di omocisteina 184
Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review 183
Differential distribution of epilepsy in patients with different types of dementia: a single-centre, retrospective study 179
Controllo totale di crisi con l’associazione lamotrigina-gabapentin in un caso di epilessia sintomatica. 176
Rischio di iperomocisteinemia in pazienti con Epilessia, portatori del diplotipo C677T/A1298C della MTHFR 175
Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study 175
A sensitive gas chromatograpic assay for the determination of serum viloxazine concetration using a nitrogen-phosphorus selective detector". Ther. Drug Monit., 6:484-488, 1984. 173
Aspetti neuropsichiatrici dell'epilessia 172
Non-convulsive status epilepticus after ischemic stroke: a hospital-based stroke cohort study 171
Antidepressant drugs and seizure susceptibility: From in vitro data to clinical practice 170
An epidemiological study of the clinical impact of pharmacokinetic anticonvulsant drug interactions based on serum drug level analysis 169
FORCED NORMALISATION: OBSERVATION WITH NEW ANTIEPILEPTIC DRUGS 168
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD 167
FORCED NORMALISATION: A RETROSPECTIVE ANALYSIS OF RISK FACTORS 167
A study on the metabolism of dipropylacetamide to dipropylacetic acid in rats 163
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 162
Repetitive transcranial magnetic stimulation induced slow wave activity modification: A possible role in disorder of consciousness differential diagnosis? 162
Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia 158
Effect of viloxazine on serum carbamazepine levels in epileptic patients 156
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) 154
Is retinal assessment useful in epileptic patients with hyperhomocysteinemia? 152
CARBAMAZEPINE VALNOCTAMIDE INTERACTION IN EPILEPTIC PATIENTS - IN-VITRO IN-VIVO CORRELATION 151
A critical role of NO/cGMP/PKG dependent pathway in hippocampal post-ischemic LTP: modulation by zonisamide 150
Effects of psychotropic drugs on seizure threshold 148
Diurnal fluctuations in plasma drug levels:studies with valproic acid and carbamazepine 147
Dipropylacetic acid plasma levels; diurnal fluctuations during chronic treatment with dipropylacetamide 146
Carbamazepine-viloxazine interaction in patients with epilepsy 146
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs 144
Accidents in patients with epilepsy: types, circumstances, and complications: a European cohort study 142
Effect of valpromide on the pharmacokinetics of Carbamazepine-10,11-epoxide 141
Antiepileptic drug comedications in clinical practice 141
The contribution of inter-ictal SPECT in the evaluation of patients with epilepsy: Possible additional uses on the basis of selected cases [Il contributo della SPECT inter-critica nella valutazione del paziente con epilessia: Possibili ulteriori indicazioni sulla base di alcuni casi selezionati] 139
Attivita' parossistica ed agenti farmacologici: attivazione ed inibizione 137
Identification of amoebae in the CSF in a patient with meningoencephalitis. 136
THE EFFECT OF COMBINING VIGABATRIN AND TIAGABINE, TWO DRUGS WITH COMPLEMENTARY GABAERGIC MECHANISMS, AGAINST NMDA-INDUCED EXCITOTOXICITY 135
Crisi epilettiche indotte dall’assunzione di leflunamide in pazienti in terapia con carbamazepina 135
Prevenzione dell’epilettogenesi: revisione della letteratura, raccomandazioni terapeutiche, proposte di ricerca 131
Neuroprotective effects of levetiracetam against kainic acid toxicity are mediated by inhibition of lipid peroxidation 130
Differential interactions of valproic acid and valpromide with Carbamazepine in man 130
Normalizzazione forzata e fattori di rischio: un'analisi retrospettiva 129
Disturbi del linguaggio e farmaci antiepilettici: analisi prospettica dei possibili fattori di rischio 129
Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. 129
Prime esperienze su efficacia e tollerabilità della tiagabina in pazienti con epilessia farmacoresistente 127
COULD LAMOTRIGINE BE USEFUL IN STATUS EPILEPTICUS - A CASE- REPORT 126
The effect of lamotrigine on peripheral nerves. 125
Meccanismi eccitotossici in un modello sperimentale in vitro: effetti della lamotrigina sul rilascio di amminoacidi eccitatori 122
CONTRIBUTION OF INTERICTAL BRAIN PERFUSION SPECT IN ASSESSING PATIENTS WITH EPILEPSY 119
Lamotrigina ed effetti elettrofisiologici sul sistema nervoso periferico. 117
Effetto della viloxazina sui livelli ematici di oxcarbazepina e dei relativi metaboliti 117
Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs. 116
Lamotrigina ed effetti elettrofisiologici sul sistema nervoso periferico 115
Withdrawal of antiepileptic drugs: guidelines of the Italian League Against Epilepsy 115
INFLUENCE OF COMEDICATION ON THE METABOLISM OF VALPROATE 112
Neuroprotective effect of remacemide hydrochloride against NMDA-induced excitotoxicity in isolated chick embryo retina 112
Ruolo dei farmaci antiepilettici nella neuroprotezione da ischemia cerebrale 112
ELEVATION OF PLASMA PHENYTOIN BY VILOXAZINE IN EPILEPTIC PATIENTS - A CLINICALLY SIGNIFICANT DRUG-INTERACTION 110
The 894G > T (Glu298Asp) variant in the endothelial NOSgene and MTHFR polymorphisms influence homocysteine levels in patients withcognitive decline. 110
Effects of remacemide and lamotrigine on MNDA-induced excitotoxicity in isolated chick embryo retina 109
Il concetto di normalizzazione forzata in epilettologia 109
Evaluation of Tricyclic Antidepressant Plasma Levels by an Automated Enzyme Immunoassay (EMIT) in Comparison to a High-Performance Liquid Chromatographic Method 108
Epilepsy Study Group of the Italian Neurological Society. Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis. 107
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients 106
Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment 106
Single-dose kinetics of primidone in acute viral hepatitis 106
Efficacia della lamotrigina nelle crisi con caduta 106
Marcato effetto sinergico terapeutico dell'associazione lamotrigina-valproato in pazienti con epilessia farmaco-resistente 106
Coenzyme Q10, Hyperhomocysteinemia and MTHFR C677T polymorphism in Levodopa-treated Parkinson’s disease patients 105
Specific Patient Features Affect Antiepileptic Drug Therapy Decisions: Focus on Gender, Age, and Psychiatric Comorbidities 105
Risk factors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis 104
INTERACTION OF LAMOTRIGINE WITH SODIUM VALPROATE 102
Pharmacokinetics and therapeutic plasma monitoring of antiepileptic drugs 102
EFFECTS OF THE ANTIDEPRESSANT DRUG VILOXAZINE ON OXCARBAZEPINE AND ITS HYDROXYLATED METABOLITES IN PATIENTS WITH EPILEPSY 101
Liquid chromatographic assay of lamotrigine,a new antiepileptic drug, by a hig-speed column 101
Sodium valproate and valpromide:Differential interactions with carbamazepine in epileptic patients 101
Increased dipropylacetic acid bioavailability from dipropylacetamide by food 101
Objective cognitive dysfunction assessment in patients with subjective cognitive complaints: does it allow an early differentiation between demnetia and pseudo-dementia? 101
Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia 100
Phenylethylmalonamide in essential tremor.A double-blind controlled study 100
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study 99
Neuroprotective effects of lamotrigine and remacemide on excitotoxicity induced by glutamate agonists in isolated chick retina 99
Pharmacokinetics of phenylethylmalonamide (PEMA) after oral and intravenous administration 99
The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: Evidence for a pharmacodynamic interaction 98
The importance of drug interactions in epilepsy therapy 98
Morbidity in patients with epilepsy: type and complications: a European cohort study 98
Interazione della carbamazepina con la valnoctamide: dati "in vitro" ed in pazienti con epilessia 98
VIGABATRIN-INDUCED DECREASE IN SERUM PHENYTOIN CONCENTRATION DOES NOT INVOLVE A CHANGE IN PHENYTOIN BIOAVAILABILITY 97
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 97
Principles and current issues of antiepileptic drug therapy 96
LAMOTRIGINE IN RESISTANT CHILDHOOD EPILEPSY 95
CLINICALLY RELEVANT ANTI-EPILEPTIC DRUG-INTERACTIONS 95
Intracellular calcium increase in epileptiform activity: Modulation by levetiracetam and lamotrigine 95
Valproic acid-ethosuximide interaction: A pharmacokinetic study 95
Limited place for plasma monitoring of new antiepileptic drugs in clinicalpractice. 93
Totale 13.483
Categoria #
all - tutte 68.053
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.053


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.099 0 167 23 42 22 3 66 55 25 152 194 350
2022/20232.741 235 172 96 214 257 257 29 182 1.156 17 80 46
2023/2024637 68 122 60 69 46 130 15 26 2 29 8 62
2024/20253.325 55 45 89 154 158 75 41 962 867 151 188 540
2025/20268.572 268 615 572 764 692 2.129 989 1.029 992 276 109 137
2026/2027530 187 343 0 0 0 0 0 0 0 0 0 0
Totale 20.269